Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04415359

Acronym

AMPCOVID-19

Enrollment

700

Registered

2020-06-04

Start date

2020-08-01

Completion date

2020-12-31

Last updated

2021-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Keywords

COVID-19, SARS-CoV-2, ARDS, ICU, Pregnant women, Pregnancy, Fetus, Middle East Respiratory Syndrome, MERS, Maternal respiratory impairment, Medical Assisted Procreation, MAR, Frozen embryos

Brief summary

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 43 Years

Inclusion criteria

* Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age * Patient who has already signed a consent to management

Exclusion criteria

* Patient who expressed opposition to participating in the study

Design outcomes

Primary

Measure	Time frame
Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period	12th week of Amenorrhea

Countries

France

Outcome results